AR and nonpapillary renal cell carcinoma: The androgen receptor (AR) can promote progression and hematogenous metastasis in ccRCC through ASS1P3/miR-34a-5p/ASS1 and miR-185-5p/HIF-2a/VEGF signaling, respectively [5, 6].